← All investors
About
Age1 Age1 is a longevity-focused venture capital fund investing in companies that target biological aging mechanisms. The thesis is straightforward: aging is the primary risk factor for most major diseases, and addressing it directly is both scientifically sound and commercially viable. The firm makes early-stage investments in longevity therapeutics and supports founders developing novel approaches to extending healthy lifespan. Age1 is part of the emerging longevity investment category that ha
Industries
Biotech
Stage focus
SeedSeries A
Geography
US
Raising from Age1?
I've worked with founders across the industrial stack. If Age1 is on your list, I can help you map the introduction path, sharpen the narrative, and run a tight process.
Talk to Dan